Appleton Group LLC increased its position in shares of SPDR S&P Biotech (NYSEARCA:XBI) by 24.2% during the second quarter, Holdings Channel reports. The fund owned 8,133 shares of the exchange traded fund’s stock after buying an additional 1,585 shares during the period. SPDR S&P Biotech accounts for 0.7% of Appleton Group LLC’s holdings, making the stock its 18th largest position. Appleton Group LLC’s holdings in SPDR S&P Biotech were worth $628,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of XBI. Russell Investments Group Ltd. increased its position in shares of SPDR S&P Biotech by 61.7% in the second quarter. Russell Investments Group Ltd. now owns 49,141 shares of the exchange traded fund’s stock valued at $3,792,000 after buying an additional 18,746 shares in the last quarter. Bray Capital Advisors increased its position in shares of SPDR S&P Biotech by 120.3% in the second quarter. Bray Capital Advisors now owns 15,610 shares of the exchange traded fund’s stock valued at $1,205,000 after buying an additional 8,525 shares in the last quarter. Boston Advisors LLC acquired a new position in shares of SPDR S&P Biotech during the second quarter valued at approximately $213,000. Meridian Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech during the second quarter valued at approximately $432,000. Finally, FineMark National Bank & Trust increased its position in shares of SPDR S&P Biotech by 7.4% in the second quarter. FineMark National Bank & Trust now owns 5,210 shares of the exchange traded fund’s stock valued at $402,000 after buying an additional 360 shares in the last quarter.

Shares of SPDR S&P Biotech (XBI) opened at 74.47 on Friday. SPDR S&P Biotech has a 52-week low of $53.15 and a 52-week high of $82.38. The stock’s 50 day moving average price is $78.58 and its 200-day moving average price is $71.46.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.watchlistnews.com/spdr-sp-biotech-nysearcaxbi-position-raised-by-appleton-group-llc/1474536.html.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with Analyst Ratings Network's FREE daily email newsletter.